 
| Course: |
Tanning Beds Revisited
|
| Target Audience: |
| This activity is intended for the oncologist. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
| AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
| Faculty |
Editor
William Ershler, MD
INOVA Fairfax Hospital Cancer Center, Fairfax, VA;
Director, Institute for Advanced Studies in Aging
Washington, DC
Executive Editor
Leslie Coplin
Managing Editor
Neill Kimball
Authors
Jerome W. Yates, MD
Hematology/Immunology Unit
National Institute on Aging, NIH
Peer Reviewer
V.R. Veerapalli, MD
Staff Clinician, INOVA Fairfax Cancer Center
Falls Church, VA
|
| Subjects: |
- Tanning Beds Revisited
- Responses, Albeit Few, for Ipilimumab-Treated Melanoma Patients with Brain Metastases
- Recurrent Meningioma: Systemic Therapy
- Free Light Chain Levels Offer Predictive Value for Both Myelofibrosis and Myelodysplasia
- Treatment Decisions for Patients with Newly Diagnosed Multiple Myeloma
|
| Objectives: |
- to present the latest information regarding diagnosis and treatment of various types of cancer
- to present prevalence/surveillance data and long-term follow-up results of chemotherapy/radiation regimens
- to describe new advances in the field of oncology
|
| Financial Disclosure: |
Clinical Oncology Alert's Editor, William Ershler, MD; peer reviewer, V.R. Veerapalli, MD; author Jerome W. Yates, MD; executive editor, Leslie Coplin; and managing editor, Neill Kimball report no financial relationships relevant to this field of study.
Copyright 2012 AHC Media LLC. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
